ANDA 209684, held by Accord Hlthcare. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 209684 (Isosorbide Mononitrate), held by Accord Hlthcare, was first approved by FDA on Oct 24, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 24, 2017 | Original application | Approved | None posted |
| Isosorbide Mononitrate30MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate60MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate120MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters